Australia approves CoronaVac and Covishield and opens the way for the entry of thousands of vaccinated foreigners

CANBERRA — Australia has approved CoronaVac and Covishield vaccines, allowing travelers and foreign students immunized with them to enter the country. As the national immunization rate approaches 80% of the population vaccinated with at least one dose and 45.6% with both, Canberra will begin in November to eliminate one of the strictest border controls imposed in the world to contain the Covid-19 pandemic.

Flexibilization:Travelers from Brazil who are vaccinated will be able to enter the UK without having to quarantine, says the newspaper

CoronaVac, from the Chinese laboratory Sinovac, is one of the most used anti-Covid vaccines worldwide, with applications from Indonesia to Brazil and Turkey. CoviShield is the version of the vaccine from the University of Oxford and the AstraZeneca laboratory produced by the Serum Institute of India, the world’s largest manufacturer of vaccines. Australia uses Pfizer, Moderna and AstraZeneca vaccines in its campaign, so travelers who have taken these immunizations will also be free to enter the country.

In Germany:Travelers from Brazil are exempt from quarantine and may enter the country only with a negative Covid test

The announcement, made on Friday, opens the door to thousands of foreign students who were excluded from Australia during the pandemic as, according to the main Australian drug regulator, the Therapeutic Goods Agency, the entry of immunized travelers into the country it will only be released to people who have received “nationally recognized vaccines”.

“Very soon, we can open international borders again,” said Prime Minister Scott Morrison. “This will start to happen from next month.

Several European countries have also said they will accept CoronaVac as part of their entry permit policy for vaccinated foreigners. The US must do the same, as it will open the door to travelers from China. Approved by the World Health Organization (WHO) for emergency use, the vaccine, however, is not recognized in the UK or New Zealand.

Sinovac’s vaccine, produced with the inactivated virus, has efficacy rates ranging from 50% to 80% in preventing symptomatic Covid-19, lower than Pfizer (88%) and Moderna (93%) vaccines, for example. , which use a more modern technology known as messenger RNA (mRNA).

International education is a lucrative source of revenue for Australia, having turned over an estimated $11 billion in New South Wales alone in 2019. More than 57,000 students are estimated to be abroad, according to the government state. China is the biggest source of international students in Australia, followed by India, Nepal and Vietnam, according to the country’s Department of Commerce.

About Abhishek Pratap

Food maven. Unapologetic travel fanatic. MCU's fan. Infuriatingly humble creator. Award-winning pop culture ninja.

Check Also

Moraes is drawn as rapporteur for action that asks for a national plan against monkeypox – News

Minister Alexandre de Moraes, of the Federal Supreme Court (STF), was chosen as …